BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21769864)

  • 1. Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.
    Chimento A; Sirianni R; Zolea F; De Luca A; Lanzino M; Catalano S; Andò S; Pezzi V
    J Cell Physiol; 2012 May; 227(5):2079-88. PubMed ID: 21769864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation.
    Sirianni R; Capparelli C; Chimento A; Panza S; Catalano S; Lanzino M; Pezzi V; Andò S
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):100-10. PubMed ID: 22906881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
    Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
    Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of anabolic-androgenic steroids on aromatase activity and androgen receptor binding in the rat preoptic area.
    Roselli CE
    Brain Res; 1998 May; 792(2):271-6. PubMed ID: 9593936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stacking anabolic androgenic steroids (AAS) during puberty in rats: a neuroendocrine and behavioral assessment.
    Wesson DW; McGinnis MY
    Pharmacol Biochem Behav; 2006 Mar; 83(3):410-9. PubMed ID: 16603236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation.
    Montanaro D; Maggiolini M; Recchia AG; Sirianni R; Aquila S; Barzon L; Fallo F; Andò S; Pezzi V
    J Mol Endocrinol; 2005 Oct; 35(2):245-56. PubMed ID: 16216906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stanozolol activates the cross-talk of estrogen receptor alpha-insulin-like growth factor-1 receptor-extracellular-signal regulated kinase 1/2 in the growth plate chondrocytes of estrogen-inhibited adolescent rats in vitro].
    Zhu SY; Li YH; Ma HM; Pan SN; Chen HS; DU ML
    Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):774-8. PubMed ID: 20021813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABAB receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brain.
    Grönbladh A; Johansson J; Nyberg F; Hallberg M
    Growth Horm IGF Res; 2014; 24(2-3):60-6. PubMed ID: 24480470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
    Sonne-Hansen K; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Bcl3 gene expression mediates the anti-proliferative action of estrogen in pituitary lactotrophs in primary culture.
    Mitsui T; Ishida M; Izawa M; Kagami Y; Arita J
    Mol Cell Endocrinol; 2011 Oct; 345(1-2):68-78. PubMed ID: 21787835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development.
    Maris P; Campana A; Barone I; Giordano C; Morelli C; Malivindi R; Sisci D; Aquila S; Rago V; Bonofiglio D; Catalano S; Lanzino M; Andò S
    Endocrinology; 2015 Apr; 156(4):1251-62. PubMed ID: 25603045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.
    Sirianni R; Zolea F; Chimento A; Ruggiero C; Cerquetti L; Fallo F; Pilon C; Arnaldi G; Carpinelli G; Stigliano A; Pezzi V
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2238-50. PubMed ID: 23074235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-I mRNA levels in bovine satellite cell cultures: effects of fusion and anabolic steroid treatment.
    Kamanga-Sollo E; Pampusch MS; Xi G; White ME; Hathaway MR; Dayton WR
    J Cell Physiol; 2004 Nov; 201(2):181-9. PubMed ID: 15334653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of pubertal anabolic-androgenic steroid exposure on reproductive and aggressive behaviors in male rats.
    Farrell SF; McGinnis MY
    Horm Behav; 2004 Aug; 46(2):193-203. PubMed ID: 15256309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.
    Fu P; Thompson JA; Leeding KS; Bach LA
    J Cell Biochem; 2007 Jan; 100(1):58-68. PubMed ID: 16888814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.
    Lisztwan J; Pornon A; Chen B; Chen S; Evans DB
    Breast Cancer Res; 2008; 10(4):R56. PubMed ID: 18611244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone affects gene expression and proliferation in human prostate cancer cells.
    Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
    Int J Androl; 2011 Apr; 34(2):124-37. PubMed ID: 20546049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior.
    Matrisciano F; Modafferi AM; Togna GI; Barone Y; Pinna G; Nicoletti F; Scaccianoce S
    Neuropharmacology; 2010 Jun; 58(7):1078-84. PubMed ID: 20138062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.